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We conducted a prospective, cross-sectional study to examine and compare 
treatment coverage of lymphatic filariasis by the health system (HST) and a health 
system implemented, community-directed treatment for the control of lymphatic 
filariasis (ComDT/HS) in 44 randomly selected villages in coastal Kenya.  
Demographic information on the villages and peripheral health facilities to guide 
design and implementation was obtained from a situation analysis phase of this 
study. A series of interactive training sessions on basic biology of lymphatic 
filariasis, concept and philosophy of ComDT/HS were given to members of the 
District Health Management Team (DHMT), peripheral health staff, community 
leaders and community drug distributors (CDDs) prior to ivermectin distribution.  
An intensive sensitization process of the community by the trained peripheral health 
staff and community leaders followed before selection of the CDDs. Quantitative 
and qualitative data for evaluation of the study were collected by coverage surveys 
of randomly selected households, focus group discussions and interviews, 
immediately after the drug distribution. Treatment coverage of all eligible persons 
was 46.5 and 88% in HST and ComDT/HS villages, respectively, P < 0.001. In 
comparing treatment coverage by the two study arms in relationship to the distance 
from a health facility, coverage among HST and not ComDT/HS villages was 
influenced by distance. In Kenya, ComDT/HS can effectively be implemented by the 
regular health system and can attain coverage levels compatible with the global 
filariasis elimination goal.  
 
[Afr J Health Sci. 2006; 13: 69-79] 
 
Introduction 
The introduction of single-dose treatment 
regimens of either diethylcarbamazine (DEC) or 
ivermectin with albendazole [1] has been an 
important breakthrough for filariasis control.  
The global strategy for control of lymphatic 
filariasis has therefore, been redefined, and is 
now principally based on annual, single-dose 
treatment of all eligible members of endemic 
communities. The main challenge that remains 
for filariasis elimination is to deliver treatment 
to the endemic populations, and to sustain 
annual delivery with high treatment coverage for  
 
 
a sufficiently long period (4-6 years) to bring 
about elimination of the disease. In most 
endemic countries, sustained drug delivery to all 
high-risk communities is difficult to achieve by 
the health services alone, either because they are 
overburdened with other responsibilities and/or  
short of resources.  Additionally, lack of active 
participation of the population with official 
health treatment programmes may also be a 
drawback.  Recent research on drug delivery for 
another filarial disease, onchocerciasis, indicates 
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communities in the delivery process may be a 
solution [2].  This large, multi-country study has 
shown that community-directed treatment of 
onchocerciasis is feasible and effective in 
onchocerciasis control; and is the basis for the 
control strategy of the African Programme for 
Onchocerciasis Control (APOC) [3]. 
        Onchocerciasis was previously eradicated 
from Kenya [4] and unlike other neighbouring 
APOC countries, such as, the Sudan, Tanzania, 
and Uganda; Kenya has no similar experience 
with community-directed treatment.  Lymphatic 
filariasis in Kenya has been reported since 1910 
[5]  and the disease remains endemic in the six 
districts of Kwale, Mombasa, Malindi, Kilifi, 
Tana River and Lamu in coastal Kenya where 
about 2.5 million people [6] are at risk of 
infection.  Recent epidemiological studies report 
microfilaraemia prevalence in these areas as 15-
25 % [7-10] and antigenaemia as 35% and 
above[7,10].  Additionally, the situation in the 
Lake Victoria Region remains unclear but there 
is strong speculation for presence of lymphatic 
filariasis in the region. In preparation for the 
ongoing Global Programme to Eliminate 
Lymphatic Filariasis (GPELF), we participated 
in a two phase, multi-country study of 
community-directed treatment of lymphatic 
filariasis between July 1997 and October 1999.  
Other participating countries were Ghana, India, 
Myanmar and Vietnam. The purpose of the 
study was to compare the effectiveness of a drug 
delivery strategy based on mass-treatment by the 
regular health service (HST) with that of 
community-directed with health system 
involvement at the implementation stage only 
(ComDT/HS).  The findings from the Kenyan 
site and their implications for both Kenya's 
National Programme for Elimination of 
Lymphatic Filariasis (NPELF) and GPELF are 
discussed.  Ethical approval to conduct this 
study was given by the Kenya Medical Research 
Institute’s Ethical Review Committee.  
 
Study Design and Methods 
Study area  
The study area covered both Kilifi and Malindi 
districts, two of the six districts in coastal Kenya 
(Fig 1).  The selection of these two districts was 
based on their known endemicity of filariasis as 
revealed by historical data and recent research 
findings including those of Phase I of the current 
study.  The communities are rural and mostly 
engage in subsistence agricultural and fishing 
activities. The study units were half districts, 
thus giving a total of four implementation units 
for both districts. The southern part of each 
district was arbitrarily assigned to the HST arm 
and the northern to the ComDT/HS arm (Fig 1).   
 
Situation analysis (Phase 1) 
Prior to implementing the study, we conducted a 
situation analysis study-Phase 1 [11].  Basic data 
on the socio-economic situation, knowledge and 
perception of filariasis, presence and 
performance of health services and other 
information relevant to the design of the 
implementation phase, were collected.  Briefly, 
the framework of the district health system in 
Kenya has three broad levels namely, the district 
hospital, the health centers and the dispensaries.   
In both the study sites there was a total of 2 
district hospitals, 6 health centers and 34 
dispensaries. Health facilities in both the study 
districts were few compared to the population 
(830,000) they were expected to serve. A 
shortage of health workers to man these health 
facilities was observed in both districts. In 
communities without health facilities, residents 
had to walk long distances of up to 19 Km to the 
health centers or dispensaries. Being the lowest 
level of the health system's interaction with the 
communities, we chose the dispensary for 
implementation of this study.   
        At the village level, there are village health 
committees whose responsibility is to oversee 
the interests of the local community in the local 
health facility. Their duties include general 
maintenance of the health facility, fund raising, 
administration of the cost-sharing scheme, and 
sometimes, collection of supplies from the 
district level. A total of 360 households were 
sampled from each of the two districts. Of 720 
persons interviewed, 99% reported that they 
knew about elephantiasis and hydrocele and it 
was reported that there existed well-defined 
terminologies, "matende" and, "mshipa wa 
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individuals associated elephantiasis to 
mosquitoes.  Thus, 67.5% had no knowledge 
about this association and attributed the disease 
to heredity (14.4%), fate/destiny (10%), evil 
spirits (1.7%), collection of “bad fluid” in the 
body and fever (5.7%) and the remainder 
associated it to various diets.  With regard to the 
burden of the disease, it was clearly indicated 
that the disease was an impediment to carrying 
out normal activities (marriage, leadership roles) 
and 76% knew that the disease could be treated 
or prevented by modern medicine. According to 
the health workers interviewed, the community 
members were not to be expected to distribute 
drugs independently.  The health workers felt 
that the health staff should be involved in some 
way as problems due to lack of adequate 
knowledge on how to handle drugs, risk of 
overdosing the minors and loss of credibility of 
the programme by the community due to lack of 
non-medical persons would make the 
programme fail. Selection of study villages 
We selected a total of 40 villages from the four 
implementing units. Eight of the villages had a 
dispensary within the village (dispensary 
villages) while the other 32 villages had the 
dispensary located 5 or more Km away (non-
dispensary villages). The 40 villages were 
equally assigned to either ComDT/HS or HST 
arm. In addition to the 40 villages selected 
above, four more villages were randomly 
selected for the ComDT/HS, Research Team 
(RT)-arm to serve as reference standards for 
evaluation. The process of selection of 
ComDT/HS, RT-arm was the same in principle 
as the one used to select HST and ComDT/HS 
villages.  Therefore, a total of 44 villages from 
the two districts were selected for this study 
phase (Fig 1).  In the reference villages, both the 
health staff and the research team introduced the 
ComDT/HS concept.  In the current study, 
ivermectin tablets were obtained from 
WHO/TDR and received by the Principal 
Investigator who delivered them to the District 
Pharmacist at the district level for onward 
dispatch to the dispensaries.  In addition to the 
ivermectin tablets, the study issued drugs for 
management of side effects. Other activities 
related to the implementation of ivermectin 
delivery in the various arms, are listed in Table 
1.  
 
Table 1. Activities related to implementation of drug distribution by drug distribution 
method, ComDT Study: Kenya, 1999 
Activities HST ComDT/HS 
Training of key trainers Senior health officials Senior health officials 
Training of implementation staff Key trainers Key trainers 
IEC campaign DHMT/health worker DHMT/health worker 
Sensitisation of community Health worker Health worker 
Selection of CDDs  Community 
Training of CDDs  DHMT/health worker 
Selection of drug delivery method Health worker Community 
Decision on timetable for drug 
delivery DHMT Community 
Drug distribution Health worker CDDs 
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Sensitisation of the official health system to 
the concept of ComDT/HS and training 
Prior to the implementation of the drug 
distribution, the RT conducted sensitization 
meetings with the entire health system. Among 
issues discussed include, the APOC experiences 
with community drug distribution, the resolution 
by the World Health Organisation to have 
endemic member states eliminate lymphatic 
filariasis (World Health Assembly, Resolution 
50.29), and our findings from Phase I. 
Additionally, the concept and philosophy of 
ComDT was introduced and the plans for its 
implementation explained. The RT conducted 
interactive training for the DHMT. The training 
included lectures and plenary discussions. At the 
conclusion of the DHMT training, one member 
was nominated to become the District ComDT 
Coordinator (DCC) and act as the liaison officer 
between the health workers at the dispensary 
level, the RT and the DHMT. Subsequently, 
members of the DHMT conducted a series of 
training for peripheral health staff, community 
leaders and CDDs.  
 Sensitisation of the community and 
selection of CDDs 
At the conclusion of the training program, the 
trained peripheral health staff and community 
leaders went back to their respective villages and 
through “barazas” (public meetings) convened 
by the official administration, sensitized the 
communities on ComDT. Both posters and 
leaflets were used for community mobilization 
and sensitization campaigns. Some posters were 
posted at the trading centers, schools and 
dispensaries while leaflets were used at the 
dispensaries by the health workers as references. 
         While "barazas" were the main forum for 
sensitizing and mobilizing the communities, the 
trained community leaders also used mosques 
and churches for delivering the ComDT 
messages.  School children were also sensitized 
at school assemblies and used as a medium for 
taking the ComDT messages back home. 
Furthermore, the peripheral health staff also 
used "health talks" for conveying ComDT 
messages to persons presenting at the 
dispensaries and the Public Health Technicians 
delivered the ComDT messages to the 
communities during their routine community 
visits. The community did the selection of CDDs 
at the "barazas". Two CDDs were selected from 
each ComDT village and attended the CDD 
training as described above. 
 
 Record keeping 
A standard method of record keeping for both 
arms of the study was agreed upon. Each 
person's height, as surrogate for weight was 
measured using a standard measuring stick 
provided by the Project.  The stick was graded in 
centimeters: 90-119cm, 1 tablet; 120-140cm, 2 
tablets; 141-158cm, 3 tablets; 158cm and above, 
4 tablets.   Record keeping stationery was also 
provided to both arms by the Project.  
Additionally, the ComDT/HS arm was provided 
with referral cards for filling in the identification 
details and remarks on any side effects that the 




Evaluation was based on a total of 752 house 
coverage surveys, including 817 semi-structured 
interviews (SSI) with household heads, 65 SSI 
with drug distributors, health workers and key 
informants; and 14 focus group discussions 
(FGD).  The drug distribution period varied 
from two to four weeks and evaluation followed 
soon thereafter. All 44 villages in the study were 
selected for the final household coverage survey.  
In each village, 20 households were selected and 
the head of the household or a designated adult 
member, who was present during the drug 
delivery, was the interviewee.   Additionally, 12 
villages were randomly selected for qualitative 
data collection from among the 44 villages. This 
was for comparison of the process and 
implementation of the drug distribution 
strategies by the two methods.  
         Quantitative data were collected by 
administration of questionnaires in the coverage 
survey and analyzed by SPSS program. 
Qualitative data were coded and analyzed by 
Textbase Beta software.  All tools for data 
collection had previously been developed, tested 
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country workshops. Since both quantitative and 
qualitative results of the ComDT/HS, RT-arm, 
the reference standard, did not differ from those 
of ComDT/HS, they have been reported along 
with and as ComDT/HS findings. All quotes 
reported in this study are those captured by the 
evaluation tools with high frequency. 
Results 
Drug distribution and treatment coverage 
In the HST arm, the peripheral health staff 
distributed the drugs through a central point such 
as the dispensary or the school, while in the 
ComDT/HS arm the CDDs distributed the drugs 
mainly on a house-to-house basis.  In very few 
cases, the CDDs asked persons who were 
difficult to catch at their homes to assemble on a 
given date at some central location in order to 
receive their drugs.  Both arms supervised the 
swallowing to ensure that those who got the 
drugs actually swallowed them. The coverage 
survey questionnaire was administered to 752 
sample households and overall, a total of 3,465 
people were interviewed.  Female respondents 
were slightly more (51.4%) than male 
respondents but the mean age was the same for 
both sexes.  Respondents on average were 27.2 
years.  We defined treatment coverage as the 
percentage of respondents who reported to have 
received and swallowed the tablets among the 
3,465 people interviewed. With respect to the 
distribution method, treatment coverage was 
46.5 and 88% by the HST and ComDT/HS arm, 
respectively (P < 0.001; Table 2).  Coverage was 
the same for males and females, and there was 
not much variation by age.  Of the surveyed 
population not treated, those under the HST 
were more (53.5%) than those under the 
ComDT/HS arm (12.0%) and the difference was 
significant (P < 0.001).   
                  











































It is known that health care utilization is greatly 
influenced by distance to the nearest health 
facility.  We therefore, assessed whether 
distance to the facility affected the results of the 
present study, where the health worker had to 
travel the same distance to provide treatment 
(HST) or introduce Com-DT/HS. As described 
in the methodology above, selection of study 
villages was stratified by distance to the nearest 
dispensary with some of the study villages 
located within 5 Km of the dispensary and 
others at more than 5 Km distance.  As one 
would expect, the treatment coverage among the 
HST villages was much lower in the distant 
villages than those located close to the 
dispensary. However, among the Com-DT/HS 
villages the distance factor did not seem to affect 
the treatment coverage and it was similar for 
villages close or far from the dispensary. With 
respect to Com-DT/HS, this response was given: 
 “In fact going house to house was the 
best thing because you reach even those who 
can not walk. The people liked it because they 
felt it was not interfering with their daily duties, 
drug distributors were people they knew and 
they had faith in them.” (Health Worker)  
      Almost everyone (2351) who received the 
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persons claiming not to have swallowed.  In the 
few cases where the drugs were not swallowed, 
reasons given for failure to swallow were not 
unexpected.  In some cases it was due to 
religious affiliation or suspicion that the drugs 
were for contraception or that it was a 
government conspiracy to decimate the coastal 
people.  
 “Education is important.  They also 
think it is for family planning.  In fact, even at 
home there is my co-wife who never took the 
drugs for fear of death.” (FGD) 
Sensitisation process, Selection of CDDs 
and Awareness of the drug delivery  
From the qualitative data, we received the 
following responses in the ComDT/HS 
communities with respect to sensitization:  
 “The health officer was going from 
house to house telling people there would be 
drugs for hydroceles and elephantiasis.” (Key 
Informant)  
It was clear that the sensitisation process had 
emphasized the role of the community in CDD 
selection: 
 “Yes, as I said we also trained the chiefs 
and they helped us by calling barazas (public 
meetings). We told them about the project. The 
Assistant chief told the Wananchi (Public) about 
the selection of the CDDs, who we took for 
training. The Wananchi are the ones who 
participated with the selection of the CDDs.” 
(Health Worker)  
         From the house survey, some 388 out of 
392 (99.0%) and 308 out of 360 (85.6%) 
respondents in Com-DT/HS and HST, 
respectively, reported that they were aware of 
the drug distribution programme.  However, 
there was a significant difference between the 
HST and Com-DT/HS, with 52 respondents 
(14.4%) being unaware of the drug distribution 
in HST compared to 4 (1.0%) in Com-DT/ HS 
arm.  Information, Education and 
Communication (IEC) materials also played a 
role in creating awareness in community 
members: 
“Yes, I have heard about the drugs, in 
fact I saw the posters at the clinic door but I 
have not received them (drugs).” (FGD) 
      We also wanted to know whether the 
respondents were clear about the disease target 
that the drug was for.  Although the respondents 
in the Com-DT/HS arm were more aware of the 
existence of the drug delivery, they were less 
clear (16%) about its purpose than in the HST 
arm (29%) and this difference was statistically 
significant (P < 0 .001).   
 
Record keeping, side effects and their 
management 
The evaluation did not reveal any difference in 
record keeping between the two arms.  Among 
the 752 respondents, 96% reported to have 
experienced no side effects.  Side effects were 
reported more often by the Com-DT/HS than by 
the HST arm. They included giddiness (1.1%), 
fever (0.8%), headache (0.3%), vomiting (0.3%) 
and myalagia (1%). Persons showing side effects 
in the ComDT/HS arm were issued with referral 
cards and referred to their village dispensary for 
management.  
   “Very few people reported headaches 
and dizziness, but when they took panadols, all 
the symptoms subsided..” (Health Worker) 
 
Discussion   
In this study, Com-DT/HS performed well and 
achieved high treatment coverage (88.0%).  
Although it is not yet known precisely what 
level of treatment coverage is required to 
achieve global elimination of filariasis, 
computer simulations suggest that coverage of 
about 80% over a 5 years period may be 
sufficient to interrupt transmission [12].  Based 
on this criterion, it appears that Com-DT/HS in 
Kenya can achieve the treatment coverage 
required for the elimination of lymphatic 
filariasis.  In contrast, the treatment coverage 
achieved by the HST arm was far below what 
may be expected to achieve transmission 
interruption.   
       Health-care utilization is greatly influenced 
by distance to the nearest health facility [13].  
The distance of the community to the health 
facility did not seem to affect treatment coverage 
in the Com-DT/HS villages where it was the 
same for villages close or far from the 
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qualitative data is that CDDs in the Com-DT/HS 
were considered more motivated to ensure the 
collection and distribution of the ivermectin 
tablets, even if some of them had to travel longer 
distances than the health workers.  
       Since the GPELF is dependent on several 
rounds of drug distribution, it may be argued 
that it is premature to conclude that the 
successful coverage we achieved with one 
experimental round would always be achieved in 
subsequent rounds in a large-scale situation. It is 
recommended therefore, that community 
sensitisation and training of CDDs remain 
continuous and intensive in order to give CDDs 
more confidence in what maybe viewed as a 
duty for the medical professionals, create a 
forum for feedback and addressing any hiccups 
that a national PELF may experience thereby, 
empowering the communities to gain ownership 
of the program.  However, as much as gaining 
ownership of a program such as this is 
important, limitations of the community must be 
acknowledged before making unrealistic 
demands on them.  Appreciation of the efforts 
required for daily subsistence may leave little 
capacity for rural communities to provide 
voluntary support to such programs [14] and 
hence affect the sustainability.  In the present 
study, remuneration of the CDDs was a 
contentious issue and some communities devised 
different ways for cash and kind incentives such 
as using the cost-sharing funds at their health 
facilities to remunerate their CDDs. 
      In Kabarole district, Uganda initial 
community efforts to support ivermectin 
distributors for river blindness control, proved 
inadequate and the presence of an active 
HIV/AIDS programme with a condom social 
marketing component, provided an opportunity 
for the drug distributors to retail condoms. 
Retailing of condoms facilitated making of some 
income by the drug distributors, promoted 
sustainability of ivermectin distribution as well 
as addressing other important health issues [15]. 
The health service and other partners with 
ongoing community activities at national PELF 
sites should therefore, avail similar opportunities 
to the communities as an option for community-
devised CDDs’ incentive mechanisms.  Caution 
must be taken, however, to ensure that availing 
and implementing alternative mechanisms for 
CDDs' incentives does so with community 
participation and the ComDT philosophy is not 
violated.  Mutabazi and Duke 15 have observed 
low or non-participation of women in 
onchocerciasis treatment in Uganda and 
suggested that women should not only 
participate but also should be available for 
appointment as CDDs.  Similarly, Askew and 
Khan [16], in a study of community-based 
delivery of family planning made a similar 
suggestion. In the present study women 
participated in both the barazas and selection of 
CDDs, and up to 53% of the CDDs were female.        
          However, in informal discussions on the 
composition of CDDs, the community indicated 
that married women were tied by the demanding 
domestic chores and it was unwise to invest in 
unmarried female CDDs as they would end up 
marrying outside the community and be 
unavailable for subsequent rounds of 
distribution. Therefore, as suggested in a parallel 
study in Ghana, communities understand the role 
that their community members can perform best 
and should be allowed to select their own CDDs 
[17]. Moreover, selection of CDDs by the 
community was found to be a useful indicator 
for predicting sustainability and monitoring 
progress towards self-sustenance of drug 
delivery in Uganda [18]. Nearly everybody who 
received the drugs swallowed them, and 
compliance with treatment was not a problem.  
During the sensitizations, the importance of 
community versus personal gains from the 
treatment was emphasized and under no 
circumstances were drugs for absent members 
left with the community for onward delivery.  
        The high compliance may therefore be 
attributed to the drug swallowing observation 
approach adopted by both arms.  To sustain such 
high compliance in any national PELF, the same 
approach is recommended. There were few cases 
of persons who adopted a "wait and see attitude" 
but on realizing that those who complied gained 
almost immediately, for example, from 
expulsion of intestinal worms, they would 
demand the drugs. Ancillary benefits such as 
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observation and has been described as a possible 
means of improving compliance in a study of 
community-based treatment of onchocerciasis in 
Sierra Leone [19]. The observation that there 
will always be "wait and see attitude" 
individuals underscores the importance of 
having enough drug supplies, their availability 
over a defined, reasonable distribution period, 
reliable and accessible outlets as well as their 
perceived ancillary benefits. In the current study, 
our data suggest that one of the reasons for the 
greater awareness in the Com-DT/HS arm, 
maybe the active involvement in the preparatory 
process of  people at the community level.  All 
people who took part in the various group 
discussions in the Com-DT/HS mentioned that 
they had been informed about the drug 
distribution. The importance of involving the 
community has been noted in onchocerciasis 
control [20,21].  
         The finding that ComDT/HS arm was less 
clear about the purpose of the drugs and that it 
also reported more side effects than the HST 
arm, maybe explained by the difference in the 
medical orientation between the drug 
distributors in the two arms.  Health workers in 
the HST arm would be more confident in 
emphasizing the purpose of the drugs and any 
side effects to be expected.  Similarly, health 
workers would also tend to acknowledge more 
correctly any side effects and dismiss the minor 
ones leaving them unreported.  In Phase I of this 
study, health workers had expressed their doubts 
in the community conducting duties of the 
medical profession successfully. However, 
during the evaluation of the current Phase, the 
benefits of involving the community appeared to 
outweigh this concern. Both the health workers 
and the community expressed appreciation of 
the community's contribution in drug 
distribution and even suggested the need to 
integrate other health services, for example, 
drugs for treatment of Schistosoma 
haematobium.   As a health problem of high 
priority among communities receiving treatment 
for filariasis, integration of control of 
schistosomiasis with filariasis has been 
previously recommended [22] and its feasibility 
within the national PELF should be investigated.  
          In Kenya, diethylcarbamazine/albendazole 
combination is currently being used for filariasis 
elimination.  This alternative strategy has well-
documented ancillary benefits and it can be 
expected that its use will not affect community 
compliance.  In the present study, side effects 
were few, minor and could all be handled at the 
level of the dispensary. The safety of the co-
administration of antifilarial drugs was 
confirmed in a review of 17 studies from 
multiple sites [23].   
         In this study, some of the communities 
residing in sparsely located homesteads 
indicated that provision of bicycles would have 
eased the CDDs duties. Yet others pointed out 
that provision of bicycles would be tantamount 
to undermining sustainability of the program 
since the communities would always look-up to 
the project for bicycle maintenance or divert the 
bicycles’ use for personal and/or commercial 
gains. Drug delivery in PELF is not a year-long 
engagement and as long as the ComDT 
philosophy is upheld, using bicycles for personal 
and/or commercial gains to earn an income 
during the "off delivery periods" could turn out 
to be an innovative way for CDDs to earn an 
income, stay motivated and remain in the 
program for its life-span. Such observations 
emphasize the need for PELF to be sensitive and 
flexible enough to switch or combine different 
drug distribution strategies as maybe demanded 
by different situations. Similarly, salt fortified 
with DEC is an effective control strategy and 
was successfully used to eliminate lymphatic 
filariasis in China and several other countries 
[24].  
         In the neighbouring Tanzania, DEC-
fortified salt has not only been shown to be 
effective in causing dramatic reductions in 
microfilariae, but also appear feasible for 
integration in large scale control programs based 
on community participation [25,26]. Hence, 
DEC medicated salt can and should be used as 
an additional synergy where applicable, for 
enhancing lymphatic filariasis elimination [27]. 
        
Conclusion 
As shown, in Kenya, ComDT can be effectively 
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service. In one round of drug distribution, 
ComDT achieved high levels of treatment 
coverage that appear adequate for filariasis 
elimination. To sustain it, some kind of incentive 
or compensation for the CDDs efforts was 
recognized as important.  Although it should be 
noted that our observations are derived from one 
round of treatment only, this method of drug 
delivery can be recommended for PELF in 
Kenya and other similar sites.  However, in view 
of the phasing out approach of PELFs, ComDT's 
need for organizational support, supervision and 
sustainability, other methods of drug delivery 
should still be explored, not for use in 
competition with the community drug delivery 
method, but to enhance it according to the 
varying needs of the different communities and 
sites.   Drug distribution in the present study was 
designed for rural communities only. As there 
are clear socio-economic differences between 
rural and urban communities, a similar approach 
may not be as successful in urban settings.  
Therefore, there is need to investigate how high 
drug coverage levels can be achieved and 
sustained in large, urban areas.    
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Fig 1: Map of Kenya Showing lymphatic filariasis-endemic and suspect sites( Inset-areas of study: Kenya 1999)  
              
